Table 2 Perioperative outcomes

Type of surgery

0.186

 CRS/HIPEC

24 (77)

6 (75)

70 (77)

105 (87)

 CRS alone

7 (23)

2 (25)

14 (15)

16 (13)

Aborted procedures

7 (23)

2 (25)

22 (24)

16 (13)

0.146

PCI

14 (5–20)

11 (4–19)

16 (9–24)

9 (5–19)

0.008*

Number of organs resected

0.129

 0

6 (19)

0 (0)

25 (28)

17 (14)

 1–7

18 (58)

7 (88)

46 (52)

81 (67)

 8–16

7 (23)

1 (13)

17 (19)

22 (18)

Number of anastomoses

< 0.001*

 0

7 (23)

3 (38)

43 (47)

55 (46)

 1–2

20 (64)

3 (38)

38 (42)

60 (50)

 ≥ 3

4 (13)

2 (25)

5 (5)

5 (4)

CC score

0.057

 CC-0/1

22 (71)

5 (63)

61 (67)

95 (79)

 CC-2/3

9 (29)

3 (38)

30 (33)

26 (21)

EBL, cc

250 (100–600)

250 (150–1450)

200 (50–500)

200 (100–350)

0.383

LOS, days

9 (6–13)

14 (8–15)

5 (4–8)

7 (5–9)

0.005*

Perioperative major morbidity

11 (35)

4 (50)

12 (13)

23 (19)

0.011*

Perioperative re-operation

6 (19)

1 (13)

8 (9)

12 (10)

0.336

Perioperative mortality

0 (0)

0 (0)

0 (0)

2 (2)

0.650

Adjuvant chemotherapy

24 (77)

5 (63)

81 (89)

105 (87)

0.093

Follow-up time, months

7 (1–13)

9 (2–27)

22 (9–34)

18 (4–33)

0.009*

Median OS, months

13 (3–31)

9 (2–NR)

33 (21–NR)

42 (15–NR)

< 0.001*

 1-year OS

10 (54)

3 (44)

63 (85)

74 (82)

 3-year OS

2 (14)

3 (44)

20 (45)

27 (54)

 5-year OS

0 (0)

3 (44)

11 (39)

9 (43)

Median PFS, months

9 (3–13)

7 (2–15)

12 (5–21)

12 (4–33)

0.063

 1-year PFS

7 (32)

2 (25)

36 (48)

49 (49)

 3-year PFS

1 (5)

1 (13)

9 (22)

13 (24)

 5-year PFS

1 (5)

0 (0)

6 (19)

5 (15)